It will also be essential to understand to what extent (potency and durability) each virus (measles, mumps, and rubella) contribute to the MMR-enabled antitumor activity and if it can effectively target and eradicate minimal residual disease and distant metastases in experimental cancer models, then clinical studies. The gene discussed is MRC1; the disease is mumps infectious disease.